Tumor cells of Epstein-Barr virus (EBV)-associated
factor (CSIF), is a pleiotropic cytokine produced mainly by activated T cells and T-cell clones, activated monocytes, and activated B lymphocyte^.""^ IL-10 inhibits expression of interferon-y and IL-2 production by the TH1 subset of Thelper cellsI5 and can directly inhibit T-cell growth. 16 In macrophages, L 1 0 suppresses synthesis of certain cytokines at the transcriptional level and downregulates major histocompatibility complex (MHC) class I1 molecules resulting in reduced antigen-specific T-cell IL-10 is also a growth factor for mast cells" and supports immune responses by inducing proliferation and differentiation of activated B cells into antibody secreting cells and by promoting immunoglobulin isotype switch." IL-10 shows structural and functional homology to the gene product of the EBV BCRFl open reading frame that is expressed during the lytic cycle of infection2' and often referred to as viral IL-10 (vIL-10). 13 Moreover, cellular IL-10 (cIL-10) shows autocrine growth supporting activity for EBV-infected B cells in vitro.21 cIL-l0 was also found in various EBV-infected and noninfected B-cell lines" as well as in EBV' ARL cases? ' Likewise, IL-4 has B-cell growth and differentiation promoting functions, induces isotype switch to IgE, and upregulates CD23 expression.= Produced by TH2 cells, IL-4 acts as an autocrine growth factor on these cells. Similar to IL-10 and augmenting its effects, IL-4 promotes mast cell growth and inhibits THl cell activity in antiparasitic and other immune reaction^.^^.^"
We report on expression of cIL-10 and vIL-10, as well as IL-4, in a large series of HD including LMP1' and LMPlcases and in six HD-derived cell lines. Controls consisted of 17 ARL, six normal tonsils, and tonsils from eight patients with infectious mononucleosis (IM), the clinically apparent form of primary EBV infection." Though nonneoplastic, the atypical cells occurring in IM share a number of morphological and phenotypical properties with HRS cells, such as the expression of cytokines and activation antigens." Discrimination between EBV' and EBV-cytokine expressing cells was achieved by applying a simultaneous in situ hybridization procedure with nonisotopic detection of the abundant EBV-encoded small nuclear transcripts, EBER-1 and -2, and isotopic detection of cIL-10 transcript^.^,^^ 
MATERIALS AND METHODS

Tissues.
Formalin-fixed and paraffin-embedded lymph nodes from 63 HD cases typed according to the Rye Conference Classification, 17 AIDS-related lymphomas (Table l) , and tonsillar tissue from eight patients with the clinical diagnosis of IM were drawn from the files of the Institute of Pathology, University Hospital Benjamin Franklin, Berlin, Germany. Six paraffin-embedded normal tonsils with slight to moderate follicular hyperplasia without necrosis served as further controls. The morphological and immunophenotypical details of these tonsillar IM tissues were recently described."
Cell lines, phytohemagglutinin-blasrs. The Hodgkin's diseasederived cell lines (HDDCL) L428, L540, and L59lZ8 were obtained from Dr V. Diehl, Cologne, Germany. CO and HoZ9 were kindly provided by Dr D.B. Jones, Southampton, UK, and K"Hz3' was a gift from Dr H. Kamesaki, Kyoto, Japan. Paraffin-embedded cell pellets of the EBV-producer cell line B95-8, donated by Dr N. Muller-Lantzsch, Homburg, Germany, served as a control for the detection of lytic cycle gene products. Supernatants for enzymelinked immunosorbent assay (ELISA) determinations were harvested 48 hours after seeding of the cells at an initial density of 5 X IOs/ mL.
Peripheral blood leukocytes were purified over a Hypaque (Pharmacia, Uppsala, Sweden) gradient and cultivated for 72 hours in the presence of 10 mg/mL PHA (phytohemagglutinin-M; GIBCO-BRL, Eggenstein, Germany).
Immunohistology. Four micrometer sections of paraffin-embedded tissue blocks were stained by the immunoalkaline phosphatase (APAAP) method using newfuchsin as chromogen." The primary monoclonal reagents were CSL-4, a cocktail of four antibodies specific for LMPI, antibody PE2 against EBNA2, antibody BZ.1 specific for BZLFl (ZEBRA) protein, and the antibodies Ber-H2 (CD30), L26 (CD20), PFI (specific for the T-cell antigen receptor P-chain), PG-M1 (CD68). and C3D1 (CD15). With the exception of PFI, which was from T-cell Sciences, Cambridge, MA, all primary antibodies, as well as rabbit antimouse immunoglobulin and APAAP-complex, were purchased from DAKO, Glostrup, Denmark. Both PE2 and BZ.l required microwave irradiation (10 minutes in 10 mrnoVL citrate buffer at 650 W) to obtain staining in paraffin sections.
Probes. cRNA probes were prepared by subcloning of cytokine gene fragments in the run-off transcription vector pGEMl (Promega Biotec, Heidelberg, Germany). The CL-l0 probe was the 1.0-kb EcoRYHindIII fragment of pH5C" (%8191, ATCC, American Type Culture Collection, Rockville, MD). The IL-4 probe was subcloned as a 310-bp Nhe ZIEcoRI fragment of pcD-hIL-4" (#57592, ATCC). The L -6 cDNA probe was the 0.6-kb EcoRYPst I fragment of ~X M 3 0 9 ;~ generously provided by Genetics Institute, Boston, MA. The nucleic acid sequences of all cytokine probes were determined on the DNA sequencer 373 (Applied Biosystems, Foster City, CA) and proved to conform to published data. After linearization of the run-off vector constructs with appropriate restriction enzymes, T7, T3, or SP6 RNA-polymerases (GIBCO-BRL, Eggenstein, Germany), respectively, were employed to obtain transcripts of either the antisense (complementary to mRNA), or sense (anticomplementary, negative control) strands. The 640-bp Apu I-Acc I BCRFIIvIL-IO probe (71% sequence identity with the human IL-l0 cDNA), as well as the pBluescript-based plasmid with the BCRFl sequence outside the IL-IO homology, were kindly provided by Dr D. Emilie, Villejuif, France. For the generation of vIL-IO specific RNA probes, Kpn I and Acc I restriction endonucleases were used for antisense and sense probes, re~pectively?~ To obtain the BCFWl probe outside the L-l0 homology region, Stu I endonuclease was used for antisense, and AccI for sense probes. 23 Transcription and labeling of RNA probes were performed as outlined previously?" Briefly, for in situ hybridizations 60 pCi of U of either SP6 or T7 RNA polymerase). The reaction was allowed to proceed for 60 minutes at 40°C. The plasmid DNA was digested with 25 mg/mL RNase-free DNase I in a mixture containing 2.5 mg/mL of yeast tRNA and 10 U of RNase inhibitor for I O minutes at 37°C. Free ribonucleotides were removed by phenol-chloroform extraction followed by ethanol precipitation. To increase the penetration into tissue, the size of the [95S]-labeled RNA probes was adjusted to 50 to 200 bases length by a controlled alkaline hydrolysis in 80 mmoVL NaHCOJ120 mmoVL Na2C03 pH 10.2/10 mmoVL dithioFor personal use only. on November 11, 2017. by guest www.bloodjournal.org From threitol at 60°C. After neutralization in 0.2 mol/L sodium acetate/ I % acetic acid pH 6.0/10 mmol/L dithiothreitol, and ethanol precipitation, RNA probes were stored at -80°C. The average specific activity was 1.3 X 10' c p d p g . EBER 1 and EBER2 specific pBluescript-based vectors: prepared from plasmids pJJJl and pJJJ2 kindly provided by Dr J. Amand, Manchester, UK, were used for the generation of digoxigenin-labeled RNA probes by substituting [35S]-labeled by digoxigenated uridinetriphosphate (Boehringer-Mannheim, Mannheim, Germany) at a concentration of 0.5 mmollL in the above reaction.' EBERI and EBER2 probes were used in combination.'
In siru hpbridizntion. The procedure, including prehybridization, hybridization, removal of nonspecifically bound probe by RNase A digestion, and further washing procedures, was performed as described.'.74 In brief, sections were deparaffinized in xylene, rehydrated in graded ethanol baths, treated in 0. , and air dried before autoradiography. l n case of combined in situ hybridization with EBER probes, autoradiography was preceded by detection of bound digoxigenin by immunohistology using alkaline phosphatase-coupled Fah fragments of digoxigenin-specific antibodies (Boehringer Mannheim) and the chromogen newfuchsin." Immunostained slides were dehydrated by quick rinses in graded ethanols before coating with the autoradiographic emulsion. Autoradiography was performed by dipping the dehydrated slides into Ilford G5 nuclear emulsion (Ilford, Mobberley Cheshire, UK) melted at 42°C and diluted 1:l in 0.6 mol/L ammonium acetate. After 2 hours of drying, the slides were stored in light-proof boxes containing desiccant and exposed at 4°C for 3 to I O days. The exposed slides were developed in Kodak D19 developer (Kodak, Hemel Hampstead, UK) for 2.5 minutes, rinsed in l % acetic acid, and fixed in Kodak Fixer for 3 minutes. After extensive washing in tap water, the slides were finally counterstained in hematoxylin and mounted in Kaiser's glycerol gelatin.
With respect to both the EBER probes and [%]-labeled probes, no differences in sensitivity were noticeable when noniaotopic in situ hybridization for the detection of EBER or radioactive in situ hybridization for the detection of cytokine gene transcripts were run in parallel instead of being used in combination. Furthcr controls consisted of hybridizations with sense RNA probes for EBER in combination with antisense probes for cytokine genes and vice versa in a simultaneous in situ hybridization procedure. These experiments showed only a weak homogeneously distributed autoradiographic background signal for sense probes in the presence of specific signals for the antisense probes.
In situ hybridization using sense probes for EBER or cytokine genes alone showed only weak nonspecific background. Prolonged exposure times up to 4 months ensured that negative results were not due to premature termination of the exposure. The incubation of sections with Micrococcus nuclease (Boehringer Mannheim) before in situ hybridization resulted in the extinction of the specific autoradiographic signal, confirming that RNA sequences were the targets of the hybridization procedure." Cells presenting with grain counts four times above background signal as defined by hybridization with sense-strand control probes were considered positive Polprnerusc, chuin reaction. Total RNA was extracted from cell lines and peripheral blood lymphocytes (PBL), digested with DNase I and transcribed to cDNA using random hexamere primers and reverse transcriptase (RT) from Moloney murine leukemia virus (Perkin-Elmer Cetus, Weiterstadt, Germany). In brief, l pg of total cellular RNA was incubated for Reaction conditions were each I minute at 96°C and 60°C. and 2 minutes at 72°C for 30 cycles followed by a final extension for 10 minutes at 72°C.
ELISA. Culture supernatants from HD-derived cell lines were assayed for immunoreactive human IL-4, as well as human clL-IO and vIL-IO, using ELBA kits, the latter being based on antibodies reacting with both cIL-l0 and vIL-IO, according to the suppliers' recommendations (Cytoscreen, BioSource International. Camarillo, CA). The ELlSA kit for the detection of human IL-4 was supplied by H. Biermann Diagnostica, Bad Nauheim, Germany. The lower detection limits were 18 pg/mL and 15 pg/mL for human cIL-IO'' and human IL-4, respectively.
Sturisrics. Statistical evaluation was performed using the x' test with correction for continuity as devised by Yates.
RESULTS
Hodgkin 's disease. cIL-10 expression by HRS cells was detectable in 23 of 63 HD cases ( Table I ) (Fig I ) or combined in situ hybridization for the demonstration of IL-IO and EBER (Fig 2A) . The signal intensity varied, in some cases requiring up to 6 weeks of autoradiography to be clearly visible above background signal. EBV infection of HRS cells was found in 26 cases of our series, with all tumor cells expressing EBER transcripts and variable proportions of tumor cells stained with antibodies against LMPI, confirming previously reported labeling patterns.'"' Unlike LMPI, EBER transcripts were not entirely restricted to HRS cells, but also found in small numbers of reactive lymphocytes. HRS cells with cIL-l0 transcripts were found in 17 of 26 (66%) HD cases with EBER' tumor cells. In contrast, only 6 (16%) among those 37 HD cases with EBER-HRS cells showed cIL-IO expression by a proportion of tumor cells. IL-IO expression was not restricted to HRS cells, but was also observed in scattered reactive cells morphologically compatible with lymphocytes and macrophages in S1 of 63. ie, 80%. of the HD cases. In nine HD cases with EBER-tumor cells investigated by simultaneous IL-IOEBER-specific in situ hybridization autoradiographic and nonisotopic signals were not colocalized, indicating that IL-I O expression was not linked to EBV infection in small reactive cells.
Eight HD cases with EBER' tumor cells and high IL-IO transcript levels in some of these cells were also hybridized with both BCRFI probes. Whereas the 640 base BCRFI probe comprising the region of homology to the clL-I O gene showed the same pattern as the cIL-IO probe, no hybridization signal was observed with the entirely EBV-specific BCRFI probe. even after extended periods of autoradiography. BZLFI-specific immunostaining was not noticeable in any of the 23 EBV-positive HD cases. The IL-4 probe did not generate any specific autoradiographic signal when applied to S2 HD cases. The IL-6 probe, included as a control, For personal use only. on November 11, 2017. by guest www.bloodjournal.org From hybridized to HRS cells in 43 of 63 HD cases, and in all 63 cases to scattered reactive cells morphologically compatible with lymphocytes, endothelial cells, and macrophages, thus confirming the presence of sufficient levels of RNA tranAn average of 2 to 3 weeks of autoradiographic exposure was required to obtain signal intensities with the IL-6 probe similar to those seen with the cIL-l0 probe after 4 to 6 weeks of exposure, indicating lower transcript copy numbers for cIL-IO relative to IL-6.
HD-derived cell lines. The EBV-cell line Ho showed IL-l0 protein in culture supernatant at a concentration of 4.15 ng/mL by ELISA and specific RNA transcripts in cytocentrifuge preparations by in situ hybridization, respectively, thus further confirming the specificity of the IL-l0 probes. All other HD-derived cell lines, CO, KM-H2, L428, L540, and the EBV' line L591 (EBER', LMPl ', EBNA2') did not display IL-IO expression in both assays (Fig 3, Table   2 ). IL-4 RNA and protein were not detectable in cells or supernatants by in situ hybridization or ELISA, respectively, of any of the six HD-derived cell lines. To exclude IL-4 and IL-l0 gene expression below the sensitivity threshold of both assays, sequences of the cIL-IO, IL-4, and &actin genes were amplified by PCR after RT of cellular RNA (Fig 4) . P-Actin-specific amplification products were obtained in similar amounts from all cell lines, as well as from mitogenactivated PBL. Large amounts of IL-10-specific PCR product were amplifiable from Ho RNA. The cell line, CO, produced a faint band indicating the presence of only small amounts of gene transcripts. Faint IL-4-specific bands were found after amplification of L428 and Ho RNA.
Infectious mononucleosis. Application of in situ hybridization with the [3SS]-labeled IL-IO-specific probes to sections of IM tonsils showed autoradiographic signals over scattered interfollicular and subepithelial cells with lymphoid morphology. Applying simultaneous in situ hybridization for EBER and IL-IO RNA, IL-10-specific transcripts were found in less than 1% of all EBER+ cells (Fig 5) . most of which were blasts (Fig 2B through D) . Expression of BCRFl-specific sequences was not detectable, although few BZLFIpositive cells were found, often in association with crypt epithelium (Fig 2E) . Expression of IL-4 was not detectable in the IM tonsils, neither in the expanded interfollicular areas nor within follicles.
AIDS-related lymphomas. 17 ARL with the diagnoses listed in Table 1 were tested for the presence of cellular and viral L 1 0 transcripts. All cases displayed a B-cell phenoFor personal use only. on November 11, 2017. by guest www.bloodjournal.org From type. The EBERs were detected in 12 of 17 cases, all of which also expressed LMPl with the exception of the Burkitt and Burkitt-like lymphomas. IL-10 was found in 9 of 12 EBV+ ARL, and in 2 of 5 EBV-ARL with both the C L -10 and vIL-10 probes (Fig 6) . In three cases, few neoplastic cells displayed BZLF1-specific staining (Fig 2F) , two of these cases also contained very few cells hybridizing with the BCRFl probe detecting sequences outside of the IL-10 homology region. hyperplasia (Fig 7) . Cytospin preparations of PHA-stimulated peripheral blood cells served as positive controls, displaying transcripts in up to 2% and 7% of the cells for IL-4 and IL-l0 probes, respectively. On RT-PCR, mitogenactivated PBL produced clear bands with IL-4-, IL-IO-, and P-actin-specific primers (Fig 4) . Paraffin-embedded cell pellets from the EBV-producer cell line B95-8 showed a small proportion of labeled cells with both BCRFI-probes (Fig 8) .
DISCUSSION
We have demonstrated IL-l0 expression by variable proportions of HRS cells in 40% of a series of 63 HD cases, as well as in IM blasts and mitogen-induced peripheral blood cells. All of these cells share the phenotype of activated cells. Thus, in this context IL-IO expression may be considered another marker of cellular activation. The findings further extend the panoply of cytokines demonstrated in HRS cells, HD-derived cell lines, and IM blasts. Underlining its suggested importance as a pleiotropic immunomodulatory cytokine, IL-IO RNA was also found to be regularly expressed by scattered small cells, mainly with lymphoid and macrophage morphology, in normal lymphoid tissues, in EBV-negative cells of IM tonsils, and in reactive nonmalignant, EBV-negative cells of HD. The role of these cells and the mechanism triggering their L 1 0 expression remain to be determined. L 1 0 and L 4 expression could be induced by mitogen in peripheral blood mononuclear cells. A role for IL-4 as an autocrine growth factor has previously been suggested for the cell line I~t 2 8 .~' IL-4, however, which shows a spectrum of activities similar to &l0 and which may augment L 1 0 effects, was not detectable by in situ hybridization in HD and IM in vivo. Despite its inhibitory potential in cell-mediated immune reactions, IL-4 is thus less likely to be relevant in the context of HD and EBV infection.
Unlike previously investigated ~ytokines,3*-~~.~'~' L 1 0 expression by HRS cells showed a close correlation with EBV infection of these cells and with the mixed cellularity histotype of HD. With respect to IL-IO and EBV, similar figures were found in our control group of ARL confirming 
Mean of three independent experiments with standard deviation <lo%, dimension is pg/mL. Threshold of ELISA 18 pg/rnL for IL-10 and 15
t Probe-outside of IL-10 homology region.
* (+) faint band in RT-PCR.
pglrnL for IL-4, respectively.
For For personal use only. on November 11, 2017. by guest www.bloodjournal.org From derived from fresh HD tissues, Frisan et found EBVspecific cytotoxicity only in HD with EBV-tumor cells, but not in EBV' cases. The authors concluded that tumorassociated suppression of EBV-specific T-cell responses may play an important role in the pathogenesis of EBV' HD." Interestingly, the cells forming rosettes around HRS cells seem to consist of THI rather than TH2 lymphocytes because they display a CD45RO'/IL-2' phen~type.~".~'
The number of virus-encoded gene products expressed during EBV latency is limited. In type I latency only the EBNAI antigen, as well as EBER transcripts, are expressed. This type of latency is typically found in small EBER' lymphoid cells described above, in EBV' Burkitt lymphomas, and in some EBV' carcinomas. Type I1 latency is characterized by the additional expression of LMPl and, in some cases, LMP2. This type of EBV latent gene expression is typical for EBV+ HRS cells and undifferentiated nasopharyngeal carcinoma." The full spectrum of EBV latent gene products includes five additional EBNA proteins and is realized in lymphoblastoid cell lines, frequently in PTLD and also in cases of ARL.'" With the exception of EBNAI, which the clL-10 probe (A) and the vlL-10 probe (B). Autoradiographic expogens.
EBV-specific cytotoxicity Of While LAPl, EBI6, and NF-KB may be essential components of LMPl signal other, as yet, undefined factors seem to be required to mediate the cell-specific functions of LMPl . The absence of such factors may explain the lack of IL-IO expression in HRS cells of some EBV+ HD and ARL cases, as well as L591 cells. Alternatively, IL-10 RNA levels may have been below the threshold of detection in some of these cases. The presence of IL-10 transcripts in some tumors with type I latency such as Burkitt's lymphomas in AIDS patients is not in contradiction with the proposed upregulatory role of LMP1, because IL-10 expression may merely coincide with EBV infection in these cases. In support of this interpretation, IL-10 expression, independent of EBV-infection, was found in six of our LMP-HD cases, as well as in the HD-derived cell lines Ho and Co.
In conclusion, IL-10 expression by HRS cells and ARL is more frequently detectable in EBV' cases, most of which are LMPI', than in cases not associated with EBV. Upregulated IL-10 expression may be among the factors contributing to the immunological dysfunctions observed in HD, in particular the lack of cell-mediated cytotoxicity towards LMPl expressing cells. However, IL-l0 is not consistently expressed in all HRS and ARL cells of all cases and is therefore likely to be only one of many factors contributing to the complex pattern of clinical and histological presentation of these tumors.
